Home Tools
Log in
Cart

Search Result

Search Results for " ctsc "

Targets

3

Compounds

2

Recombinant Proteins

Cat No. Product Name Synonyms Targets
T11466 GSK-2793660 Others
GSK-2793660 is an orally active and irreversible inhibitor of Cathepsin C (CTSC). GSK-2793660 is a bioactive dipeptide that can be used for the research of bronchiectasis [1] [2].
T27468 GSK2793660 HCl GSK-2793660,GSK2793660,GSK 2793660
GSK2793660 is a irreversible covalent α,β-unsaturated amide based DPP1 inhibitor.
T70381 GSK2793660 free base
GSK-2793660 is a cathepsin C inhibitor that may be useful in the treatment of cystic fibrosis, noncystic fibrosis bronchiectasis, ANCA-associated vasculitis and bronchiectasis.

Recombinant Proteins

Cat No. Product Name Species Expression System
TMPH-02628 Cathepsin C Protein, Mouse, Recombinant (His & Myc) Mouse E. coli
Thiol protease. Has dipeptidylpeptidase activity. Can act as both an exopeptidase and endopeptidase. Can degrade glucagon. Plays a role in the generation of cytotoxic lymphocyte effector function.
TMPY-00732 Cathepsin C Protein, Human, Recombinant (His) Human HEK293 Cells
Cathepsins are proteases found in many types of cells conserved in all animals, which have a vital role in mammalian cellular turnover such as bone resorption. The lysosomal cysteine protease Cathepsin C (CTSC), also kno...
TargetMol